Dive Brief:

• Kathy Wengel, Johnson & Johnson Worldwide Vice President, Supply Chain, asserts that the company's supply chain transformation has taken it from a totally decentralized multi-department approach without visibility, to a globally aligned organization, per company press release.
• The company's chain under Wengel covers the consumer, medical devices and pharmaceutical sectors.
• Plans for the future include an ongoing determination to respond to a changing market, using technology to act sooner rather than later. J&J is also heavily involved with Internet of Things (IoT), relying on the data provided to better coordinate activity between suppliers and customers.

Dive Insight:

Improvements in the Johnson & Johnson supply chain have led to significant contributions throughout the world, including the Global Pandemic Supply Chain Network (PSC), created by the UN. The PSC aims to engage health care providers with  those in need of medication during global health care crises, to which Johnson & Johnson has provided support. 

Drug quality assurance, paramount to the biopharma industry, means that the cold chain's role in maintaining strict temperature requirements and logistics organization is key for such companies as J&J. Pharma shippers demand end-to-end visibility in the supply chain in order to ensure that the integrity of their product is not compromised. The Food and Drug Administration has a role to play as well, as the FDA has implemented new serialization requirements that enable the tracking process every step of the way.